Cáncer de pulmón
Tratamiento del cáncer de pulmón de células no pequeñas en estadios I y II
Se presenta la guía práctica basada en evidencia clínica del American College of Chest Physicians (2ª edición), para el tratamiento del cáncer de pulmón de células no pequeñas (CPCNP) en estadios I y II.
Autor/a: Dres. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K
Indice
1. Bibliografía
2. Desarrollo
1. Silvestri GA, Handy J, Lackland D, et al. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998; 114:675–680
2. Goodney PP, Lucas FL, Stukel TA, et al. Surgeon specialty and operative mortality with lung resection. Ann Surg 2005; 241:179–184
3. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell cancer by the Lung Cancer Study Group. Ann Thorac Surg 1995; 60:615–623
4. Linden PA, Bueno R, Colson YL, et al. Lung resection in patients with preoperative FEV1 <35% predicted. Chest 2005; 127:1984–1990
5. Martin-Ucar AE, Nakas A, Pilling JE, et al. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005; 27:675–695
6. Watanabe S, Asamura H, Suzuki K, et al. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004; 78:999–1025
7. Jackevicius A, Cicenas S, Naujokaitis P. Limited resection of lung cancer. Acta Chir Hung 1999; 38:49–51.
8. Tsubota N, Ayabe K, Doi O, et al. Ongoing prospective study of segmentectomy for small lung tumors. Ann Thorac Surg 1998; 66:1781–1790
9. Landrenau RJ. Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1N0) non-small cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:691–698.
10. Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 129:261–267.
11. Birdas TJ, Koehler RP, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy for stage IB non-small cell lung cancer. Ann Thorac Surg 2006; 81:434–438.
12. Solaini L, Orusciano F, Bagioni P, et al. Video-assisted thoracic surgery major pulmonary resections. Eur J Cardiothorac Surg 2001; 20:437–442.
13. Daniels LJ, Balderson SS, Onaitis MW, et al. Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Ann Thorac Surg 2002; 74:860–864.
14. Mckenna RJ, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006; 81:421–426.
15. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Ann Surg 1998; 227:138–144.
16. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 1998; 22:290–294.
17. Wu Y, Hauang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002; 36:1–6.
18. Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Database of Systematic Reviews 2005 (1):CD004699 .
19. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006; 81:1013–1019.
20. Suen HC, Myers BF, Guthrie R, et al. Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg 1999; 67:1557–1562.
21. Booth CM, Shepherd FA. Adjuvant chemotherapy for resected non-small cell lung cancer. J Thorac Oncol 2006; 1:180–187.
22. Alam N, Darling G, Shepherd FA, et al. Ann Thorac Surg 2006; 81:1926–1936.
23. Pisters KMW, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small cell lung cancer. J Clin Oncol 2005; 23:3270–3278.
24. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 2006; 24(18S):7008.
25. Winton TL, Livingston R, Johnson D, et al. Vinorebline plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 2005; 352:2589–2597.
26. Douillard J-Y, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet 2006; 7:719–727.
27. Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer: update of Cancer and Leukemia Group B protocol 9633. J Clin Oncol 2006; 24(18S):7007.
28. Roselli M, Mariotti S, Ferroni P, et al. Postsurgical chemotherapy in stage IB non-small cell cancer: long-term survival in a randomized study. Int J Cancer 2006; 119:955–960.
29. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004; 350:1713–1721.
30. Hamada C, Tanaka F, Ohta M, et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small cell lung cancer. J Clin Oncol 2005; 23:4999–5006.
31. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351–360.
32. Qiao X, Tullgren O, Lax I, et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003; 41:1–11.
33. Saunders M, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiation therapy (CHART) versus conventional radiation therapy in non-small cell lung cancer: a randomized, multicentre trial: CHART steering committee. Lancet 1997; 350:161–165.
34. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation therapy for stage I non-small cell lung carcinoma: clinical outcomes in 245 patients in a Japanese multi-institutional study. Cancer 2004; 101:1623–1631.
35. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833–4839.
36. Burdett S, Stewart L. Postoperative radiotherapy in non-small cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 2005; 47:81–83.
37. Okawara G, Ung YC, Markman BR, et al. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 2004; 44:1–11.